We are a bio-pharmaceutical company dedicated to developing innovative antibiotics to address the growing concern of bacterial infections in both human and animal populations. Our pipeline includes finafloxacin and friulimicin, which we manage through non-clinical and clinical development, as well a...See more
Headquarter Germany |
Year founded 2000 (24 years) |
Funding status Private |
Company type SME |
Research Scientist